vs

Side-by-side financial comparison of BuzzFeed, Inc. (BZFD) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $56.5M, roughly 1.0× BuzzFeed, Inc.). BuzzFeed, Inc. runs the higher net margin — -47.4% vs -83.0%, a 35.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 0.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 23.6%).

BuzzFeed, Inc. is an American Internet media, news, and entertainment company with a focus on digital media. Based in New York City, BuzzFeed was founded in 2006 by Jonah Peretti and John S. Johnson III to focus on tracking viral content. Kenneth Lerer, co-founder and chairman of The Huffington Post, started as a co-founder and investor in BuzzFeed and is now the executive chairman.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

BZFD vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.0× larger
RYTM
$57.3M
$56.5M
BZFD
Growing faster (revenue YoY)
RYTM
RYTM
+36.3% gap
RYTM
36.9%
0.6%
BZFD
Higher net margin
BZFD
BZFD
35.6% more per $
BZFD
-47.4%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
23.6%
BZFD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BZFD
BZFD
RYTM
RYTM
Revenue
$56.5M
$57.3M
Net Profit
$-26.8M
$-47.5M
Gross Margin
91.6%
Operating Margin
-43.7%
-82.2%
Net Margin
-47.4%
-83.0%
Revenue YoY
0.6%
36.9%
Net Profit YoY
-186.4%
-9.6%
EPS (diluted)
$-0.72
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZFD
BZFD
RYTM
RYTM
Q4 25
$56.5M
$57.3M
Q3 25
$46.3M
$51.3M
Q2 25
$46.4M
$48.5M
Q1 25
$36.0M
$32.7M
Q4 24
$56.2M
$41.8M
Q3 24
$55.6M
$33.3M
Q2 24
$41.1M
$29.1M
Q1 24
$37.0M
$26.0M
Net Profit
BZFD
BZFD
RYTM
RYTM
Q4 25
$-26.8M
$-47.5M
Q3 25
$-7.4M
$-52.9M
Q2 25
$-10.8M
$-46.6M
Q1 25
$-12.7M
$-49.5M
Q4 24
$31.0M
$-43.3M
Q3 24
$2.1M
$-43.6M
Q2 24
$-7.5M
$-32.3M
Q1 24
$-35.7M
$-141.4M
Gross Margin
BZFD
BZFD
RYTM
RYTM
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
Operating Margin
BZFD
BZFD
RYTM
RYTM
Q4 25
-43.7%
-82.2%
Q3 25
-12.9%
-102.6%
Q2 25
-7.5%
-93.4%
Q1 25
-38.1%
-143.7%
Q4 24
7.0%
-98.6%
Q3 24
2.8%
-132.0%
Q2 24
-13.6%
-139.2%
Q1 24
-63.4%
-538.7%
Net Margin
BZFD
BZFD
RYTM
RYTM
Q4 25
-47.4%
-83.0%
Q3 25
-16.1%
-103.1%
Q2 25
-23.3%
-96.1%
Q1 25
-35.2%
-151.4%
Q4 24
55.2%
-103.6%
Q3 24
3.8%
-131.2%
Q2 24
-18.2%
-110.9%
Q1 24
-96.5%
-544.4%
EPS (diluted)
BZFD
BZFD
RYTM
RYTM
Q4 25
$-0.72
$-0.73
Q3 25
$-0.20
$-0.82
Q2 25
$-0.28
$-0.75
Q1 25
$-0.33
$-0.81
Q4 24
$0.86
$-0.71
Q3 24
$0.05
$-0.73
Q2 24
$-0.20
$-0.55
Q1 24
$-0.98
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZFD
BZFD
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$8.5M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$49.4M
$139.1M
Total Assets
$188.1M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZFD
BZFD
RYTM
RYTM
Q4 25
$8.5M
$388.9M
Q3 25
$34.3M
$416.1M
Q2 25
$29.7M
$291.0M
Q1 25
$34.3M
$314.5M
Q4 24
$22.4M
$320.6M
Q3 24
$53.7M
$298.4M
Q2 24
$45.5M
$319.1M
Q1 24
$44.5M
$201.2M
Stockholders' Equity
BZFD
BZFD
RYTM
RYTM
Q4 25
$49.4M
$139.1M
Q3 25
$75.9M
$148.8M
Q2 25
$81.1M
$-11.9M
Q1 25
$93.8M
$18.9M
Q4 24
$104.8M
$21.7M
Q3 24
$71.7M
$11.2M
Q2 24
$67.2M
$39.3M
Q1 24
$73.7M
$61.6M
Total Assets
BZFD
BZFD
RYTM
RYTM
Q4 25
$188.1M
$480.2M
Q3 25
$211.2M
$506.9M
Q2 25
$210.4M
$372.7M
Q1 25
$203.2M
$386.7M
Q4 24
$221.4M
$392.3M
Q3 24
$276.5M
$363.6M
Q2 24
$272.9M
$381.8M
Q1 24
$299.0M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZFD
BZFD
RYTM
RYTM
Operating Cash FlowLast quarter
$-11.7M
$-25.4M
Free Cash FlowOCF − Capex
$-12.0M
FCF MarginFCF / Revenue
-21.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZFD
BZFD
RYTM
RYTM
Q4 25
$-11.7M
$-25.4M
Q3 25
$1.7M
$-26.6M
Q2 25
$-10.1M
$-23.3M
Q1 25
$1.3M
$-40.4M
Q4 24
$-4.6M
$-18.8M
Q3 24
$9.6M
$-25.2M
Q2 24
$-12.4M
$-29.1M
Q1 24
$-13.3M
$-40.7M
Free Cash Flow
BZFD
BZFD
RYTM
RYTM
Q4 25
$-12.0M
Q3 25
$892.0K
Q2 25
$-10.5M
Q1 25
$956.0K
Q4 24
$-4.7M
Q3 24
$9.3M
Q2 24
$-12.5M
Q1 24
$-13.4M
FCF Margin
BZFD
BZFD
RYTM
RYTM
Q4 25
-21.2%
Q3 25
1.9%
Q2 25
-22.7%
Q1 25
2.7%
Q4 24
-8.4%
Q3 24
16.7%
Q2 24
-30.5%
Q1 24
-36.2%
Capex Intensity
BZFD
BZFD
RYTM
RYTM
Q4 25
0.5%
Q3 25
1.8%
Q2 25
1.0%
Q1 25
1.1%
Q4 24
0.3%
Q3 24
0.5%
Q2 24
0.3%
Q1 24
0.2%
Cash Conversion
BZFD
BZFD
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.15×
Q3 24
4.59×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZFD
BZFD

Advertising$25.6M45%
Commerce And Other$16.3M29%
Content$14.7M26%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons